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Abstract
Database search approaches via Mass Spectrometry (MS) are fairly accurate meth-
ods for protein identification making use of the proteins database. However, many
species, especially those within mycobacterial species are still not annotated and do
not have protein sequences in any known database sources. Although de novo peptide
sequencing approaches have been introduced to overcome that issue, their success re-
quires high quality data. Accordingly, extending proteomic database search methods
to include non-annotated mycobacteria is of great interest for a more expanded and
accurate result.
The first part of our study involves analysis of the proportion of identical in silico
tryptic peptides shared between different mycobacterial organisms relative to their
distance in phylogeny. This aims to evaluate the use of the closest annotated species’
protein database for an MS analysis of non-annotated species. The result of this
first part highlights the utility of a cross-species proteomic analysis for mycobacte-
rial species within a phylogenetic distance less than 0.3 to each other. The second
part involves the use of a six frame translation database obtained from the genome
sequence for proteogenomic annotation. This allows identification of potential novel
proteins from species with incomplete databases and may also be applied to non-
annotated species. Applied to Mycobacterium avium, this methodology allowed the
identification of 81 extra proteins not previously reported in the existing database of
M . avium.
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1. Introduction
1.1 Motivation
Mycobacterium is a genus of Actinobacteria within the order Mycobacteriales in the
family Mycobacteriaceae [1]. It comprises pathogens known to cause serious diseases
such as Leprosy and Tuberculosis in animals and in humans. Tuberculosis especially
remains a major world health problem [2]. Although BCG (Bacillus Calmette-Guerin)
is used as a vaccine, its effectiveness in human varies widely especially in adults
and the result has been less than desired [3]. Moreover, the increased rate of drug
resistance undermines drug efficacy towards the treatment of tuberculosis [4]. The
study of proteome complement expressed in cell is useful and may contain important
information regarding the functioning and activity of the disease pathogen since the
proteins are actually representative of the phenotype. Therefore accurate protein
identification from sample mixture is a useful step forward towards development of
new biomarkers, potential drug targets and vaccines.
Shotgun proteomics via mass spectrometry (MS) has emerged as the most com-
monly used analytical method for such proteomic analysis. In this technology, com-
putational methods such as database search approaches are used to analyse exper-
imental mass spectra by matching them against theoretical mass spectra derived
from database proteins [5–7]. These methods are fairly accurate but limited to the
identification of peptides from known genomes, excluding those from non-annotated
organisms such as Mycobacterium kansasii and Mycobacterium shottsi. De novo
peptide sequencing approaches [8,9] which extract amino acid sequences directly from
the experimental spectra have been introduced to overcome this problem but their
success requires high quality data with high signal to noise ratios, high spectral resolu-
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tion and mass accuracy. To date, de novo sequencing of peptides in complex mixtures
therefore remains challenging.
In this thesis, we investigated two approaches towards the identification of proteins
from mycobacterial species which are non-annotated or have incomplete databases.
We study the feasibility of a cross-species analysis within mycobacterial species to
evaluate the use of the closest annotated species database to carry out database
search-based analysis of spectra generated from MS analysis of non-annotated or-
ganisms. We then study the use of proteogenomic analyses both for mycobacterial
species with incomplete databases as well as sequenced but non-annotated mycobacte-
rial species by creating an automated six frame translation database from the genome
sequence.
1.2 Analytical technique
Mass spectrometry (MS) is one of the most commonly used analytical technique
for protein identification. The process of an MS analysis can be divided into three
fundamental parts comprising sample preparation, mass spectrometry phase and data
analysis. Tandem mass spectrometry or MS/MS involves multiple steps of mass
spectrometry for more accurate characterization. Figure 1.1 illustrates the workflow
of an MS/MS analysis.
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Figure 1.1: Tandem mass spectrometry [10].
During the sample preparation, complex mixtures are fractionated to reduce com-
plexity and to remove the highly abundant component of the proteome. Proteins
can be separated according to their size, hydrophobicity, charge, isoelectric point or
affinity. A number of methods can be used to fractionate sample mixture including
Isoelectric focusing [11–13] in which proteins are separated based on their isoelectric
point, Liquid Chromatography [14] or SDS-PAGE [15]. Enzymes such as trypsin are
added to digest the proteins. Tryptic digests should then be purified so that molecules
that interfere with ionisation/detection such as salts, detergents and chaotropes are
eliminated. Digested peptides are then loaded onto the mass spectrometer to be
analysed. This process is shown in Figure 1.2.
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Figure 1.2: Sample preparation.
In the mass spectrometry phase, samples are ionised and parent ions are selectively
fragmented by collision induced dissociation for an MS/MS analysis. Fragmented ions
are extracted and are separated according to their mass-to-charge ratio(m/z). The
separated ions are then detected and the signal is sent to a data system where the
m/z ratios are stored together with their relative abundance for presentation in the
format of a m/z spectrum.
Once the spectra are generated, computational methods are needed to extract the
correct amino acid sequence from the spectra: this is the post-mass spectrometry
phase and consists of interpreting the displayed spectra from the mass spectrometry
to get information about the protein present in the sample. Some existing methods
for computational analysis of MS/MS data are briefly reviewed in Chapter Two.
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1.3 Thesis outline
This report is comprised of five Chapters. In Chapter 2, we present some commonly
used methods for protein identification. Examples of database search approaches
are described in Section 2.1 and some de novo sequencing algorithms are explained in
Section 2.2. The advantages and disadvantages of these existing method are discussed
in Section 2.3. The feasibility of cross-species analysis is studied in Chapter 3. A
brief overview is presented in Section 3.1. We describe our methodology for the cross-
species analysis along with the result obtained throughout this part in Section 3.2.
Section 3.3 introduces the conclusion of how far a cross-species analysis holds true.
Chapter 4 advances the proteogenomic analysis of M . avium and M . kansasii using
six frame translation. Section 4.1 shows a brief overview of Chapter 4. We present our
methodology for the proteogenomic analysis in Section 4.2 and Section 4.3 provides
the result from the proteins identification. We summarize our work and present the
result obtained throughout the study in Chapter 5.
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2. Existing methods to interpret
MS/MS data
Reliable interpretation of the MS/MS spectra is critical for providing confidence in
the protein identification. Several methods have been developed to address this task
including database searches, which make use of an in silico database to match the-
oretical MS/MS spectra with the experimental MS/MS spectra. The limitation of
database search methods for identification of peptides within an unknown genome
can be solved in principle by the use of de novo sequencing algorithms which extract
sequence information directly from the MS/MS data without the need for a sequence
database. We present in this chapter a brief review of major existing database search
and de novo sequencing approaches and discuss their advantages and limitations.
2.1 Database search methods
Database search algorithms involve the scanning of all known peptide MS/MS spectral
space to find the best match to experimentally observed MS/MS spectra. Peptides
that have mass matching with the experimental peptide mass within some tolerance
are assigned to be candidates for Peptide Spectral Matching(PSM). Their sequences
in the database are converted into hypothetical MS/MS spectra to enable the compar-
ison. The experimental spectrum is then matched with the theoretical one obtained
from the candidate peptides database and a score is assigned for each PSM. The
database search method’s workflow is illustrated in Figure 2.1. The most popular
database searches engines include Sequest [5], Mascot [6] and X! tandem [7].
6
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Figure 2.1: Database search method workflow.
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2.1.1 Sequest
Sequest was developed by Eng et al [5] originally in 1994 as one of the earliest database
search methods. It was developed to interpret mass spectra from experimental result
using a protein database by converting the protein sequences to a predicted MS/MS
spectra for tryptic peptides and then by comparing them with the experimental spec-
tra. Although various versions of Sequest exist currently, the basic algorithm remains
approximately the same. It can be described as comprising four steps.
The first step consists of the tandem mass spectra data reduction. The mass-to-
charge ratio of the fragment ion is rounded to the nearest integer, noise filtering is
processed by eliminating all but the 200 most abundant ions and then the remaining
ions are renormalized by 100. The abundances of fragment ion within +−1 u of each
other are equalized to the higher value.
In the second step, the experimental spectra are matched to a proteolitic peptide
sequence in the database according to their molecular weight. In silico generated
tryptic peptide sequences are retrieved and scanned to find the best combination
of amino acids that closely match the mass of the experimental peptide, the amino
acid masses are summed until the in silico peptide mass falls within a defined mass
tolerance from the experimentally observed mass. The masses of the fragment ions
were obtained using Equation 2.1:
bn =
∑
an + 1 yn = MW −
∑
an (2.1)
where an is the mass of amino acids, bn is the type b− ion and yn is the type y− ion.
Equation 2.1 equates to the mass-to-charge ratio value for fragment ions in the charge
+1 state that is considered by the Sequest scoring routine.
Step three involves the preliminary scoring method. Each in silico peptide se-
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quence is scored depending on the number of predicted fragment ions denoted by ni
that match ions observed in the experimental spectrum within a defined mass toler-
ance, their abundances im, the continuity of an ion series, the presence or absence of
an ammonium ion and the total number of predicted sequence ions nt. The score is
then given in Equation 2.2:
Sp =
(
∑
im)ni(1 + β)(1 + ρ)
nt
(2.2)
where β represents the type-b and y ions continuity and ρ represents the presence
or absence of an ammonium ion and their respective amino acids in the predicted
sequence. This is a preliminary score and the top 500 amino acid sequences obtained
using this score are then analysed in the 4th step using the cross correlation analysis.
The fourth step is the most important for scoring in Sequest. It entails the com-
parison of each of the 500 preliminary PSMs to the experimental spectra. Their
spectra are constructed in the following way. Values that represent mass-to-charge
ratio of type-b ion or type-y ion are assigned a magnitude of 50.0. A magnitude
of 25 is assigned to mass-to-charge ratio within +−1 u of type- b ion or type- y ion.
Mass-to-charge ratio of type-a ion and mass-to-charge ratio within +−1 u are assigned
a magnitude of 10. The experimental spectra represented as x and the reconstructed
spectra represented as y from the database are then compared using the cross correla-
tion formula Rτ (Equation 2.3) and the final score is denoted by Xcorr as calculated
in Equation 2.4 and normalized to 1:
Rτ =
n−1∑
i=0
x[i]y[i+ τ ] (2.3)
XCorr = R0 −
(∑τ=75
τ=−75Rτ
)
151
(2.4)
where τ is a displacement value. The Xcorr measure is an absolute measure of
spectral quality and closeness of fit to the model spectrum. To distinguish correct
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identification from false positives, the difference between the normalized cross corre-
lations of the first and the second best amino acid sequences are used.
2.1.2 Mascot
The Mascot search engine algorithm is based on probability MOWSE scoring. The
ions score is −10×Log(P ) where P is the probability that the match occurs randomly
[6]. The proteins score is then derived from the ion score as a non-probabilistic basis
for ranking protein hits. The Mascot method interface is shown in Figure 2.2 where
the user can choose the database to search the dataset against, and select the enzyme
to be used for digestion. The modification can also be set as ’fixed’ or ’variable’ as
required. It also allows the user to select peptide and MS/MS tolerance as well as
the desired peptide charge.
Figure 2.2: Mascot search engine interface [6].
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The report from a Mascot search result is set to represent peptides with score
higher than the significance threshold which depends on the size of the experimental
MS/MS dataset and database used. For each identified protein, information about
all of the peptides identified can be obtained by clicking on its accession number.
The protein view is also included for the top one, two or three proteins where the
percentage of the sequence coverage is given and the protein sequence is displayed
with the experimentally observed peptides identified in bold red .
2.1.3 X!Tandem
X! Tandem differs from Sequest in the way the scoring function is performed. X!
Tandem considers only b and y type ions. Only peaks that match to the hypothetical
spectra are used in this model [7]. The preliminary score used in X! Tandem is defined
in Equation 2.5:
y/bScore =
(
n∑
0
Ii × Pi
)
(2.5)
where Ii represents the peaks intensities while Pi takes the value 1 if the peak was
predicted and 0 otherwise.
This preliminary score is multiplied by the factorial of the number of b ions and
y ions which gives the Hyperscore as defined in Equation 2.6:
HyperScore = y/bScore×Nb!×Ny! (2.6)
X! tandem assumes that the amino acid sequence with the best score is the only
possible correct match and to evaluate the correctness of the first best score, it looks
at the distribution of lower scoring hits.
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2.2 De novo peptide sequencing
De novo peptide sequencing involves extracting amino acid sequence information
directly from the MS/MS without prior knowledge of any protein database. With
an idealized process of fragmentation in the mass spectrometer, a peptide would be
cleaved at random between every two consecutive amino acids and a single charge
would be retained on only the N-terminal fragment [16]. This would enable the de-
termination of the peptide sequences by simply converting the mass differences of
consecutive ions in the spectrum to the corresponding amino acids. However in prac-
tice, the fragmentation process in mass spectrometer is far from ideal [16]. Therefore,
a scoring function is used to evaluate the match between the candidate peptide and
the given experimental spectrum in a de novo sequencing approach. A typical de
novo sequencing workflow is illustrated in Figure 2.3. Here we describe the algorithm
of two de novo sequencing methods namely Pepnovo [8] and PEAKS [9].
An Introduction to Bioinformatics Algorithms www.bioalgorithms.info
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Figure 2.3: De novo sequencing algorithm.
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2.2.1 Pepnovo
Like most de novo peptide sequencing approaches, Pepnovo [8] uses a spectrum graph
created from the MS/MS spectra to assign the peptide sequences. The nodes are
cleavage sites having mass m and score Score(m,S) where S represents the spectrum.
The score for each node is computed as a function of the probability PCID(
−→
I |M,S)
of detecting an observed set of fragment intensities
−→
I given that mass m is a cleavage
site in the peptide that created S and the probability PRAND(
−→
I |M,S) that the peaks
in the spectrum are caused by a random event. This score is given by the formula
2.7:
Score(m,S) = log(
PCID(
−→
I |M,S)
PRAND(
−→
I |M,S)
) (2.7)
which means that a peak intensities
−→
I is more likely to be caused by a cleavage event
if the score is positive and it is more likely to be caused by a random event if the
score is negative.
To compute the probability PCID(
−→
I |M,S), Frank and Pevzner [8] used a network
diagram as shown in Figure 2.4. V {b, y, ...} denote the vertexes in the network ex-
cluding the pos(m), N-aa and C-aa; pi denotes the v’s parents in the graph; −→pi (v)
denotes the set of values assigned to the vertexes pi(v). PCID(Iv = i|−→pi = i1, i2, ...)
is the probability of detecting the intensity i at fragment ion v given the intensities
detected at its parents. The probability PCID(
−→
I |M,S) can be decomposed in the
function of the PCID(Iv = i|−→pi ,m, S) as shown in the relation 2.8 since each vertex
v is independent of other vertexes in the network graph given that the values of its
parents are known.
PCID(
−→
I |M,S)
∏
v∈V
PCID(Iv = i|−→pi ,m, S) (2.8)
The probability of randomly observing a peak with a given intensity in the spec-
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trum is computed using the fact that each peak is distributed independently of the
others and PRAND(
−−−−→
I|m,S) are the products of the probabilities of seeing the individ-
ual peaks. This is given in Equation 2.9.
PRAND(
−→
I |M,S) =
k∏
i=1
PRAND(iI |ni1 , ni2 , ..., nid) (2.9)
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Figure 2.4: Probabilistic network for the fragmentation model of tryptic peptides.
2.2.2 PEAKS de novo peptide sequencing
The scoring for PEAKS de novo sequencing [9] is comprised of four steps involving
preprocessing, candidate computation, refined scoring and global and positional con-
fidence scoring. The first step involves noise filtering and peak centering as well as
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deconvolution of the doubly and triply charged species to singly charged ions. The
second step consists of computing the 10000 best sequences of all possible combination
of amino acids for a given precursor ion mass. PEAKS de novo sequencing method
scoring is based on penalty/reward score computing of each possible mass value in-
stead of a spectrum graph drawing. The objective is to find a sequence such that its
y and b ions maximize the total rewards at their mass values. In the third step, each
of the 10000 sequences is re-evaluated by considering a stricter mass tolerance and
a reward for immonium ions and internal cleavage ions. A recalibration of the data
is performed to account for minor deviations in MS/MS data. In the last step, the
confidence score is computed for the top scoring peptide sequences.
2.3 Advantage and disadvant ge of these methods
Both database search and de novo sequencing methods have their strengths and
weaknesses. Database search methods are very successful for identification of already
known peptides. The major drawback for any database search method is its limitation
to fully annotated organisms only. Although the number of sequenced organisms is
increasing with the advent of next generation DNA (Deoxyribonucleic acid) sequenc-
ing, there are still many species that are not annotated or only poorly annotated.
Other limitations of database search approaches include the lack of assignment of a
large portion of the MS/MS data due to the incompleteness of the database or low
quality MS/MS spectra.
Non-annotated organisms as well as species with incomplete proteomic databases
therefore need other ways such as de novo sequencing to interpret spectra from
MS/MS data. However, the use of de novo sequencing necessitates backbone cleavage
between each pair of adjacent amino acids which only occurs with very high qual-
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ity data. As a result, de novo sequencing methods are known to be accurate for
identification of single amino acids but still lack accuracy when identifying peptide
sequences.
Therefore, we discuss in the next chapter the feasibility of extending database
search methods to non-annotated species by the use of its closest sequenced and
annotated species database. In particular, we describe a methodology based on cross-
species analysis within mycobacterial species for proteomic spectrum matching.
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3. Cross-species analysis
3.1 Overview
We have developed a methodology to study the feasibility of a cross-species proteomic
analysis within mycobacteria. This method aims to evaluate the use of the closest
species database to carry out database search methods to assign spectra generated
from MS/MS analysis of non-annotated organisms. The feasibility of the cross-species
analysis in our study is evaluated according to the closeness of pairs of mycobacte-
rial species in phylogeny proportionally to the number of identical tryptic peptides
shared between them. The closeness of the species is measured using the phylogenetic
distance calculated from the 16S ribosomal RNA (16S rRNA) sequences.
We show in this project that the divergence between mycobacterial species in
terms of identical peptides is directly related to their phylogenetic distance: the
farther they are in phylogeny, the lower the number of peptides they share. This
relationship enables the estimation of the number of peptides shared between non-
annotated and annotated sp cies knowing their distance separation in phylogeny. The
result gives us insight into how far apart in phylogeny actinobacteria can be before we
lose the ability to use the proteome of a sequenced organism to interpret spectra from
a non-sequenced one. We focused our comparison on the number of tryptic peptides
because typically the protein identification is based on PSM of tryptic peptides.
17
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3.2 Methodology and Results
Two members of the Mycobacterium avium complexes (MAC) i.e M. avium (Av)
strain 104 and M. paratuberculosis (Ptb), 4 species within the Mycobacterium
tuberculosis complex (MTBC) i.e M . bovis (Bov), M. bovis BCG Pasteur (BCG),
M. tuberculosis H37Rv (HRv) and M . tuberculosis KZN (KZN) and 4 additional
mycobacterial species including M. leprae (Lep), M . ulcerans (Ulc), M . marinum
(Mar) and M. smegmatis (Smeg) were analysed as the reference annotated species.
Protein databases utilised, including the proteome files, and paralog and ortholog files
for each species were obtained from Ensembl [17]. The non-annotated species used
here to test our methodology were M . kansasii (Kans) and M . shottsii (Shot).
To evaluate the similarity between two species, the number of shared tryptic
peptides were determined taking into account that true identical peptides should be
from homologous proteins. Homologous proteins are proteins that are derived from
the same ancestor. They are referred as ”orthologs” when they are from different
species and arose from speciation and ”paralogs” if they result from duplication in
the same species. Any other shared peptides are considered to be false positive. The
closeness of two species, including non-annotated ones, was then calculated using
their 16S rRNA sequences. Thereafter, the feasibility of the cross-species analysis
of two species was measured by the proportionality of their peptides’ similarity and
their closeness in phylogeny.
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3.2.1 Comparison in terms of identical peptides
Peptide filtering
Proteins from each proteome fasta file were digested in silico with the enzyme Trypsin
using the software DBToolkit [18]. No miscleavages were allowed. The enzyme trypsin
cuts after every Lysine (K) or Arginine (R) unless it is followed by a Proline (P ). To
make our comparison meaningful, a probability search was performed to determine in
our subsequent analyses the shortest amino acid to be considered such that a peptide
match between any two species was unlikely to be a chance event. The probability was
computed for peptides of a given length starting with monopeptides and increasing in
length until the probability of the peptide’s random occurrence in any given proteome
file is smaller than 0.05.
Given the restriction that for any tryptic peptide, the C-terminal residue must
be R or K, for monopeptides, there are only two possibilities, either it is R or K.
Therefore, the probability of having R is
1
2
and likewise for K if there was only
one monopeptide. For dipeptides, the possibilities are: XR or XK where X can be
any amino acid but R, K. So the probability of getting any one specific dipeptide is:
1
18
× 1
2
if there was only one dipeptide. Pursuing this strategy, we have the probability
of getting one specific peptide of 5 amino acid as follows:
1
18
× 1
18
× 1
18
× 1
18
× 1
2
if
there was only one peptide of length 5. If N is the number of peptides of length k
in the organism, the likelihood of finding any one specific peptide of length k in that
organism is then the following:
Pr = prk ×
(
1 +
N∑
n=1
(1− prk)n
)
(3.1)
where prk denotes the previously calculated probability representing the likelihood of
finding a specific peptide of length k if there was only one peptide of that length. Since
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N is different for each organism, we used the mean of the N of all organisms used in
this study for each k and we got, Pr(monopeptide) = 0.99, Pr(dipeptide) = 0.89,
Pr(pentapeptide) = 0.03, which means that the probability that a specific peptide
of length 5 occurs by chance is 0.03. The result from these probability computations
leads us to the conclusion that the shortest peptide that can be considered as a non
random match within any given mycobacterial proteome file is a pentapeptide.
Peptide comparison
As previously stated, the database of the organisms used in this study were collected
from Ensembl [17]. We removed redundancy of the proteins within each species i.e
proteins that have exactly the same sequence were reported only once. We then
carried out in silico tryptic digests on the non-redundant proteome files for each or-
ganism and only peptides with greater than or equal to five amino acids were counted
according to the probability search described above. We then counted the number of
all shared peptides between each pair of species and then we further computed those
shared between homologous proteins. We assumed that identical peptide between
species could either genuinely be shared by ortholog proteins or by a protein and
the paralog of its ortholog. Other shared peptides were then considered to be false
positives.
The distribution of the number of identical peptides shared between ortholog
proteins in any pairwise comparison of mycobacteria is shown in Figure 3.1 which
reveals that an average ortholog protein pair shares 9 peptides and the highest peptide
count shared between two ortholog proteins is 208. However, there are some proteins
not reported to be orthologs yet they share as many peptides as two typical ortholog
proteins. An example of one such protein is shown in Figure 3.2 for the protein
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”Malate synthase” from M. avium and M. bovis BCG. These two proteins share 14
identical peptides, exceeding the number of shared peptide between most of ortholog
proteins, yet are not annotated as orthologs. The alignment from CLUSTAL W [19]
of these proteins is shown in Figure 3.3.
Figure 3.1: Distribution of peptides shared between ortholog proteins. The X-axis
shows the numbers of identical peptides shared between pair of proteins that are
ortholog. The Y-axis shows the number y (as mean for all pair of species) where y is
the number of ortholog protein that share x identical peptides for each species-pair.
.
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>EBMYCG00000012441(A0QGM8) (M. avium)
MTDRVSAGNLRVARVLYDFVNDEALPGTDIDPDSFWAGVDKVVTDLTPRNQELLRRR
DELQAQIDKWHRQRVIEPLDIDAYRDFLIEIGYLLPEPEDFTITTSGVDDEITTTAGPQLVVPV
LNARFALNAANARWGSLYDALYGTDVIPETDGAEKGSSYNKVRGDKVIAYARNFLDQAVP
LESGSWADATGLSVEDGRLQVATADGSVGLAEPEKFAGYTGQLGSPDWSVLLVNHGLHIEI
LIDPQSPVGKTDRAGIKDVVLESAVTTIMDFEDSVAAVDADDKVLGYRNWLGLNKGDLSE
EVSKDGKTFTRVLNADRTYTTPDGQGELTLPGRSLLFVRNVGHLMTNDAIVLSDGDEEKEV
FEGIMDALFTGLTAIHGLKTGEANGPLQNSRTGSIYIVKPKMHGPDEVAFTCELFSRVEDVL
GLPQGTLKIGIMDEERRTTVNLKACIKAAADRVVFINTGFLDRTGDEIHTSMEAGPMIRKG
AMKNTTWIKAYEDANVDIGLAAGFKGKAQIGKGMWAMTELMADMVEQKIGQPKAGATT
AWVPSPTAATLHAMHYHYVDVGAVQEELAGKKRTTIEQLLTIPLAKELAWAPEEIREEVDN
NCQSILGYVVRWVAQGVGCSKVPDIHDVALMEDRATLRISSQLLANWLRHGVITEEDVRAS
LERMAPLVDAQNAKDAAYQPMAPNFDDSLAFLAAQDLILTGTQQPNGYTEPILHRRRREV
KARAAQSN*
>EBMYCG00000020988(A1KJP9)(M. bovis  BCG)
MTDRVSVGNLRIARVLYDFVNNEALPGTDIDPDSFWAGVDKVVADLTPQNQALLNAR
DELQAQIDKWHRRRVIEPIDMDAYRQFLTEIGYLLPEPDDFTITTSGVDAEITTTAGPQLVVP
VLNARFALNAANARWGSLYDALYGTDVIPETDGAEKGPTYNKVRGDKVIAYARKFLDDSV
PLSSGSFGDATGFTVQDGQLVVALPDKSTGLANPGQFAGYTGAAESPTSVLLINHGLHIEILI
DPESQVGTTDRAGVKDVILESAITTIMDFEDSVAAVDAADKVLGYRNWLGLNKGDLAAAV
DKDGTAFLRVLNRDRNYTAPGGGQFTLPGRSLMFVRNVGHLMTNDAIVDTDGSEVFEGIM
DALFTGLIAIHGLKASDVNGPLINSRTGSIYIVKPKMHGPAEVAFTCELFSRVEDVLGLPQNT
MKIGIMDEERRTTVNLKACIKAAADRVVFINTGFLDRTGDEIHTSMEAGPMVRKGTMKSQ
PWILAYEDHNVDAGLAAGFSGRAQVGKGMWTMTELMADMVETKIAQPRAGASTAWVPS
PTAATLHALHYHQVDVAAVQQGLAGKRRATIEQLLTIPLAKELAWAPDEIREEVDNNCQSIL
GYVVRWVDQGVGCSKVPDIHDVALMEDRATLRISSQLLANWLRHGVITSADVRASLERM
APLVDRQNAGDVAYRPMAPNFDDSIAFLAAQELILSGAQQPNGYTEPILHRRRREFKARAA
EKPAPSDRAGDDAAR*
Figure 3.2: Non-ortholog proteins from M . avium and M . bovis BCG respectively
sharing 14 identical peptides. Highlighted peptides indicate common peptides be-
tween the proteins.
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sp|A1KJP9|MASZ_MYCBP
sp|A1KJP9|MASZ_MYCBP
Figure 3.3: Alignment of the two non-ortholog proteins from M . avium and M .
bovis.
Along with the fact that neither of these proteins has any other ortholog, this
high amount of peptides similarity between these two sequences suggests that they
may be missed in the orthologs classification. We consider peptides shared between
such pairs as false false positive since they are grouped with the false positives but
they should actually be true positive.
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In Table 3.1, the similarity of pairwise mycobacterial species is represented in
term of identical peptides. The table represents the name of the species (Species),
the total number of tryptic peptides (≥ 5 mers) in the species (Peptides), the name
of the other species compared to the species in the first column (Other Species), the
number of known ortholog proteins between the two species compared (Orth Prot),
the number of identical shared peptides between otholog proteins in these species
(Shared Pep), the false positive (FP, which is the number of peptide shared between
two non-ortholog proteins) and the false false positive (FFP, which is the number of
peptides shared between two proteins that may have been missed as being annotated
as ortholog).
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Section 3.2. Methodology and Results Page 25
Table 3.1: Number of identical peptides shared between mycobacterial species.
Species Peptides Other Species Orth Prot Shared Pep FP FFP
M . avium 95956 M. bovis 2677 11172 942 101
M . bovis BCG 2671 11163 965 90
Mtb H37Rv 2701 11256 952 101
Mtb KZN 2709 11240 965 99
M. leprae 1381 5938 423 66
M . marinum 3354 13132 1207 102
M. smegmatis 3184 8166 1632 50
M. ulcerans 2897 10947 918 108
M. paratuberculosis 4005 67748 791 35
M . bovis 75469 M . bovis BCG 3837 73952 114 13
Mtb H37Rv 3825 72864 201 44
Mtb KZN 3776 71738 251 49
M. leprae 1419 6638 333 73
M. marinum 3127 22644 879 81
M. smegmatis 2576 6691 1375 107
M. ulcerans 2755 19873 671 113
M . bovis BCG 75307 Mtb H37Rv 3774 72547 72274 273
Mtb KZN 3750 71521 327 68
M. leprae 1413 6638 330 163
M. marinum 3103 24082 868 223
M. smegmatis 2568 6684 1373 160
M. ulcerans 2747 19877 660 199
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Species Peptides Other Species Orth Prot Shared Pep FP FFP
Mtb H37Rv 76514 Mtb KZN 3847 74238 62 6
M. leprae 1419 6647 345 73
M. marinum 3158 25110 887 81
M. smegmatis 2600 6728 1392 99
M. ulcerans 2771 19266 675 16
Mtb KZN 77032 M . leprae 1421 6624 342 71
M . marinum 3173 25430 908 79
M . smegmatis 2611 6714 1396 105
M . ulcerans 2783 19240 684 16
M. leprae 32431 M. marinum 1448 6369 368 28
M. smegmatis 1363 3915 563 54
M . ulcerans 1403 5915 292 28
M. marinum 108933 M. smegmatis 3331 7872 1683 99
M. ulcerans 3820 60082 171 42
M. smegmatis 123455 M . ulcerans 2789 6722 1265 79
M . ulcerans 81470
This comparison in terms of identical peptides reveals that mycobacterial species
within MTBC share about 98% identical peptides while those within MAC share 96%.
The farthest removed mycobacterial pair studied here includes M. smegmatis and M.
avium with 9% of their peptides in common. The number of false positives is higher
when the similarity is lower which may relate to a poor ability to predict ortholog
proteins between more distant species. We compute in the next section the closeness
of two species according to their phylogenetic distance including the sequenced but
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non-annotated species namely M. kansasii and M . shottsii.
3.2.2 Comparison in phylogeny
Phylogenetic distance
An accurate way of measuring the evolutionary distance between two mycobacterial
species comprises the comparison of their 16S rRNA sequences. A reason for this is
that the 16S rRNA is highly conserved in almost all bacteria [20]; it is about 1550
nucleotides in length which is large enough to provide necessary information about
the evolution [21]. Furthermore, the function of 16S rRNA has not changed over time
which suggests that the variable region can be used for measurement of the time of
evolution [21].
The phylogenetic distance between two sequences is defined as the percentage of
nucleotides in one sequence that are different from those in another taking into ac-
count the mutation that could have occurred considering the time rate. We measure
the distance between species using their aligned 16S rRNA sequences from the Riboso-
mal database project (RDP) [22]. The distance used is the Jukes Cantor distance [23],
calculated from the Formula 3.2.
K = −3
4
log(1− 4
3
D) (3.2)
where D is the proportion of nucleotides which differs between the two sequences.
Table 3.2 lists the value of the distance between each mycobacterial species pair
considered in this study.
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Table 3.2: Phylogenetic distance computed using the 16S rRNA.
Smeg Ulc Lep Kans Ptb Bov HRv Shot Av BCG KZN Mar
Smeg 0 3.2 3.3 2.9 3.0 2.6 2.6 2.8 2.9 2.6 2.6 2.9
Ulc 0 1.7 1.1 1.3 0.7 0.7 0.4 1.1 0.7 0.7 0.2
Lep 0 1.2 1.2 1.1 1.1 1.3 1.2 1.1 1.1 1.3
Kans 0 0.8 0.8 0.8 0.8 0.5 0.8 0.8 0.8
Ptb 0 0.7 0.7 0.8 0.1 0.7 0.7 1.0
Bov 0 0.1 0.3 0.8 0.1 0.1 0.4
HRv 0 0.3 0.8 0.1 0.1 0.4
Shot 0 0.8 0.3 0.3 0.1
Av 0 0.8 0.8 0.8
BCG 0 0.1 0.4
KZN 0 0.4
Mar 0
Phylogenetic tree
Using the aligned 16S rRNA sequences from RDP, the tree of the 13 mycobacterial
species studied here was constructed to view the closeness of the species. The tree
was built using the Quicktree [24] program from the Mobyle portal web site [25] to
get the newick format and then we used biopython [26] to display the tree in Figure
3.4. The Quicktree software uses a Neighbor-joining method for the construction of
the tree.
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   _______________ M. kansasii
   |
        __________|                   ___ M. avium
 | |__________________|
 |                             |______ M. paratuberculosis
 |
       |
 |             ____ M. ulcerans
 |                  |
 |         _____|____ M. marinum
       |                     |    | 
 |                  |     |____ M. shottsii
 |      |
 |    __|            __ Mtb. KZN
 |   |  |           |
_______|   |  |           |__ M. bovis
 |   |  |           |
 |   |  |___________|__Mtb. H37Rv
 |   ______|              |
 |  |      |              |__ M. bovis BCG
 |  |      |              |
 |  |      |              |___ Mtb. F11
 |___________|      |
 |      |_______________________________ M. smegmatis
 |
 |_______________________________ M. leprae
Figure 3.4: Phylogenetic tree of mycobacterial species using distance matrix from
Mobyle portal. An outgroup was not included in this tree because we are inter-
ested in quantitative analysis of sequence divergence not in construction of a strict
phylogenetic tree per se.
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It can be seen from Table 3.2 and Figure 3.4 that the closest species to M.
kansasii and M. shottsii that have been sequenced are respectively M. avium and
M. marinum with phylogenetic distance 0.59 and 0.1 respectively. In order to es-
timate the number of peptides shared between these species, the result showing the
proportionality between the number of peptides shared and the phylogenetic distance
is presented in Subsection 3.2.3. This also enables us to determine the critical limit
in phylogenetic distance outside of which this proportionality fails, and therefore the
maximum phylogenetic distance between annotated and non-annotated organism be-
fore we lose the ability to use the former to assign MS/MS spectra from the latter.
3.2.3 Relationship between phylogenetic distance and pep-
tides shared
The correlation between phylogenetic distance and the number of peptides shared
identically between two annotated species is shown in Figure 3.5. This relationship
allows the estimation of the number of identical peptides that will be shared between
a sequenced and annotated species and non-annotated one given their distance in
phylogeny.
The comparison of mycobacterial species was represented starting with two highly
similar organisms, within the MTBC (Mtb H37Rv and Mtb KZN) whose distance is
almost 0 in the phylogeny and ending with two species far away from each other
(M. avium and M. smegmatis) with distance 2.9. It shows that the number of
identical peptides shared by two species and their distance in phylogeny are related
as expected, with the number of peptides shared decreasing from 98% to 8% and the
distance in phylogeny increasing from 0 to 3.0.
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Figure 3.5: Relationship between the phylogenetic distance and the percentage iden-
tical shared peptides.
To confirm the feasibility of a cross-species proteomic analysis that includes non-
annotated species, we looked at the number of false positives among the identical
peptide between each pair compared. Figure 3.6 shows the distribution of false pos-
itives found in our study. For species that are significantly similar to each other,
the number of false positives can be less than 2% of all their shared peptides. The
significant increase in apparent false positives with increasing phylogenetic distance
is interesting and may simply reflect increasingly inaccurate identification of true
orthologs between species.
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Section 3.2. Methodology and Results Page 32������
������
�
����
����
����
����
���
����
����
����
����
���
���������������������������
�����������������
�������������������
�����������������
��������������������
���������������
���������������������
�������������������
��������������������
�������������������
���������������������
�����������������
�����������������
�������������������
����������������������
��������������������
������������������
������������������
������������ ������
����������������������
��������������������
����������� ������
������������������
�����������������
������������������
����������������
�����������������
���������������
�������������������
������������������
��������������������
���������������������
��������������������
������������������������
�������������������
����������������������
��������������������
���������������������
�������� �����������������������������
�
� �
� �
� � �
� � �
� �
� �
� �
� �
� � �
� �
�
Figure 3.6: False positive rate distribution between all species-pairs compared. The
false positive rate here is the proportion of the number of identical peptides shared
between two non-ortholog proteins over all identical peptides.
3.2.4 Peptide conservation in mycobacterial species
Figure 3.5 shows expectedly that the fraction of peptides shared between two species
decreased rapidly as their phylogenetic distance ranges from 0 to 1. However, un-
expectedly this relationship tends to approach a constant value of 0.08 when the
phylogenetic distance is above 1. This suggests that there is a strong conservation
of certain peptides that are shared identically across pairwise mycobacterial species,
even when the distance in phylogeny between mycobacteria is high. This conservation
was seen to be across all mycobacterial species studied here, among them M. leprae
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which is the species with the smallest proteome of mycobacteria containing only 1600
proteins. The conserved peptides are about 2600 in number and found in approxi-
mately 700 proteins in each species. A GO (Gene Ontology) enrichment analysis of
the proteins conserved between M . avium and M. bovis are presented in Tables 3.3
and 3.4. Information about the GO enrichment of the conserved proteins was ob-
tained using the StRAnGER [27] software and the GO annotation downloaded from
integr8 [28] of each species was used as the background database. The StRAnGER
software takes as input a group of protein IDs to be analysed and a background
database of GO annotation and gives as output information about the GO enrich-
ment of the group. It uses three choices of statistical test (hypergeometric test, Fisher
exact test or χ2 test) for the identification of enriched ontological terms. Here we used
a p-value cut off of 0.01 and the Fisher exact test where the probability for a term Ti
to be over-represented is given by Equation 3.3.
P (z, n, t, x) =
 z + x
z
 t− z + n− x
t− z

 n
t
 (3.3)
n denotes the number of genes in the microarray/reference list, x the number of
genes in the array/reference list associated with the term Ti, t the number of genes
in the significant list and z the number of genes in the significant list annotated to
the term Ti.
The result shows the significant enrichment of certain catalytic and binding activ-
ity for molecular function, and transport and metabolic process for biological process
as seen in Tables 3.3, 3.4. This conservation indicates an underlying basic similarity
of a subset of proteins from all mycobacteria, which represents about half of the whole
proteome of M. leprae.
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Table 3.3: GO enrichment analysis of the conserved proteins from M . avium and M.
bovis
M. avium M. bovis
Go term p-value Go term p-value
BP GO:0045449 4.84462003847e−08 GO:0045449 3.33713057188e−11
GO:0055085 1.39227926965e−08 GO:0055085 2.3442359165e−11
GO:0055114 1.19112497643e−11 GO:0055114 3.84110521168e−11
MF GO:0016787 2.19974938984e−11 GO:0016787 6.74162947689e−11
GO:0016853 4.95378182919e−11 GO:0016829 6.38449293433e−11
GO:0016740 6.08113559508e−12 GO:0016740 9.1432417193e−11
GO:0016747 0.00354735937991e−11
GO:0016874 3.16768833386e−11 GO:0016874 1.98052685363e−12
GO:0046872 3.77875508661e−12 GO:0046872 2.57529553238e−11
CC GO:0016012 5.80362775615e−08 GO:0016012 2.36374150031e−07
GO:0030529 1.79722903226e−11
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Table 3.4: Description of the GO terms significantly enriched in the conserved proteins
from M . avium and M. bovis
Go term Description
BP GO:0045449 Regulation of cellular transcription
GO:0055085 Transmembrane transport
GO:0055114 Oxydation reduction
MF GO:0016787 Hydrolase activity
GO:0016853 Isomerase activity
GO:0016829 Lyase activity
GO:0016740 Transferase activity
GO:0016747 Transferase activity, transferring acyle group other than amino-acyl groups
GO:0016874 Ligase activity
GO:0046872 Metal ion binding
CC GO:0016012 Integral to membrane
GO:0030529 Ribonucleoprotein complex
3.2.5 Validation of the cross-species analysis
The relationship between the distance in phylogeny of pairs of mycobacterium species
and the number of their common tryptic peptides enables the determination of a
phylogenetic distance limit for the use of a cross-species analysis. Species within
the same family such as MTBC or MAC are seen to have significant similarity and
with false positive rates of less than 2% of the total number of common peptides.
The corresponding phylogenetic distance between these species are less than 0.3.
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Moreover, as the distance increases from this number, the number of tryptic peptides
shared decreases rapidly and less than 50% similarity is observed which will complicate
the cross-species proteomic comparisons, at least at the peptide level.
Application to M. avium, M. bovis BCG and Mtb H37Rv
For the validation of our analysis, we have searched M . avium, M. bovis BCG and
Mtb H37Rv MS/MS data using their respective database fasta file from Ensembl [17]
first and then re-searched each using the Mtb H37Rv database. The methodology for
protein identification used is described in Chapter 4, Subsection 4.2.2. The result is
shown in Table 3.5
Table 3.5: Result obtained from a cross-species analysis of M. avium, M. bovis BCG
and Mtb H37Rv.
# of identified # of identified % of the # of Phylogenetic
Species protein using proteins using identified proteins distance from
Mtb H37Rv file their own file using Mtb H37Rv Mtb H37Rv
Mtb H37Rv 1100 1100 100% 0.0
M . bovis BCG 1723 1780 96.80% 0.1
M. avium 221 1500 14.73% 0.8
The result shows that 1723 proteins have been identified from M. bovis BCG using
the Mtb H37Rv database while 1780 are found using its own database. The number
of protein identified from using Mtb H37Rv database is then about 96.80% of the
number of protein identified using the M. bovis BCG fasta file which is not far from
the theoretical result of 98% similarity between these two species. From M . avium,
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the experimental result of 221 proteins using the Mtb H37Rv database represents
approximately 14.73% of the whole protein identified using its own database which
also agrees with the result from the theoretical study of 14% similarity. Interestingly,
if we take the inverse of these percentages they correlate with the genetic distances:
1
96.8
= 0.01 and the genetic distance is 0.1, while
1
14.73
= 0.07 and the distance is
0.8.
Possible application to M . kansasii and M. shottsi
Knowing that the closest species to M. kansasii and M. shottsi are M. avium and M.
marinum respectively, we plotted them in the Figure 3.5 based on their phylogenetic
distance. This enabled us to estimate the percentage identical peptides between M.
marinum and M. shottsii to be 98% but only 21% for M. avium and M. kansasii.
This means that using theM. marinum database to identify spectra fromM. shottsii,
we can expect 98% true positives from the result while if we use the M. avium
database for M. kansasii, we can only expect to assign
1
5th
of the spectra that are
true matches to M. kansasii peptides; clearly this will be limiting for any proteomic
analysis of M. kansasii, suggesting that an alternative bioinformatic approach is
likely to be necessary. An experimental mass spectrometry protein identification was
produced for M. kansasii using the M. avium database and the result confirms
this theory, where we identified only 275 proteins in M. kansasii while about 1500
(∼ 18%) proteins were identified from M. avium mass spectra.
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3.3 Summary
Data from the study of a cross-species in silico analysis reveals the relationship be-
tween the tryptic peptides shared identically between two species and the phylogenetic
distance between the species. The relationship enables the evaluation of how far apart
actinobacteria can be in phylogeny before we lose the ability to use the proteome of an
annotated organism to interpret spectra from a non-annotated one. It also shows that
there is a strong conservation of about 2600 tryptic peptides accross all mycobacterial
species; these are present in 700 proteins which represents half of all proteins in the
mycobacterium species with the smallest proteome(M. leprae), and perhaps suggests
that these 700 proteins are the core, basal, essential machinery of mycobacteria, so
further examination of these may be warranted from a drug target or vaccine target
perspective.
Our data suggests that a cross-species analysis can be applied to species within
phylogenetic distance less than 0.3 such as those within the same family, MTBC or
MAC. It also suggests that proteomic analysis of non-annotated species is possible,
providing their distance from a sequenced and annotated organism is less than 0.3.
For instance, a cross-species preotomic analysis can be applied to M. shottsii using
the M. marinum database but for M. kansasii, the use of a cross-species analysis will
not enable the identification of more than 20% of the expected identified proteins
from its sample. The next part of our study describes another way of identifying
proteins from sequenced but non-annotated species like M. kansasii as well as those
with incomplete annotation by creating an open reading frame (ORF) database from
a six frame translation of the genome.
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4. Proteogenomic analyses
4.1 Overview
Interpretation of MS/MS spectra remains a big challenge in the proteome area. Gen-
erally, despite huge advancement in mass spectrometry equipment in recent years,
still typically a huge part of the whole data from MS/MS is not inferred to peptides.
One reason for such inefficiency may be the absence or incompleteness of the genome
annotation that gives rise to the protein database for the species being studied. Here
we present a proteogenomic analysis of M. avium -representing a well sequenced
species in mycobacteria- and M . kansasii representing a poorly or non-annotated
species. This analysis consists of searching the MS/MS data against the genome se-
quence database using an automated six frame translation and comparing the result
with those obtained from use of the existing protein database.
MS/MS analysis of the M. avium and M. kansasii samples were analysed using
their respective six frame translation database. In M. avium, we were able to identify
1594 proteins including 81 that had not previously been annotated in the Ensembl [17]
proteome file. Following the same experiment with M. kansasii using its six frame
translation database, we were able to identify 160 proteins from the M. kansasii
mass spectra, which is twice the number of M. kansasii proteins currently present in
the Uniprot database [29].
39
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4.2 Methodology
4.2.1 Six frame translation
There are six possible reading frames for a genome sequence. In any one reading
frame, open reading frames can exist between stop codons with each triplet of nu-
cleotides encoding an amino acid that can be predicted using the bacterial codon
table. Each open reading frame typically has a start codon. The possible start
codons for bacteria are: ATG (coded as Methionine M), GTG (coded as Valine V ),
and sometimes, TTG and CTG (coded as Leucine L). All start codons are read
as M during the translation. In bacteria, the start codon is usually preceded by a
ribosome binding site, but these remain difficult to identify in an automated scanner
due to the sequence variability of ribosome binding site. Here we therefore decided
to adopt a simpler approach, simply defining an ORF as having a start codon and a
stop codon and accepting that this will over predict the total number of ORFs in any
given bacterial genome. We wrote a python script to model the translation of the
M . avium and M. kansasii genomes requiring minimum peptide size of 20 amino
acids to conform with the shortest peptides in the Ensembl database and using ATG,
GTG and TTG as start codons. This procedure discovered some DNA sequence am-
biguities denoted most commonly by N (which can be any of the nucleotides), and
less often D, H, R, K, Y , M and S (codes described at [30]) in the M . kansasii
genome sequences. So, each triplet with one or more ambiguities was translated as X
such that the specific tryptic peptides containing these ambiguous amino acids will
be missed during the database matching but the remainder of the pepides from that
protein could still be matched. New annotations were inferred from the translated
sequences, showing the species ID, the frame in which it was read, and the start and
end positions of the potential gene in the genome. For M. avium the Ensembl acces-
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sion number was added at the end of this annotation for previously known protein
sequences in order to differentiate them from the new ORFs. Where there were some
differences in length between newly annotated sequences and Ensembl’s, the longer
sequence was used in each case in order to get as much information as possible from
it. The resultant six frame translation ORF databases were then used for assignment
of MS/MS data for proteogenomic annotations.
4.2.2 Protein Identification
Sample preparation
In general, the mycobacterial cultures were grown until mid to late log phase OD
0.6− 0.9 and were harvested by centrifugation. Cell lysis was carried out by boiling
the cell pellet in 3% SDS buffer for 30min. Whole cell lysates were prepared from
the strains M . avium and M. kansasii initially in Middlebrook 7H11 media, and
thereafter in Sautons media. Clarified cell lysate was obtained by centrifugation
at 10000g for 15 minutes to remove cell debris. Protein extracts from the culture
filtrate and intracellular lysate were concentrated on 3kDa Molecular weight cut off
filters. For each protein sample, 40µg was separated on a 12% SDS PAGE gel prior to
further analysis. Culture filtrate and intracellular protein preparations were analysed
separately.
Each gel lane was cut into 5 pieces resulting in 10 pieces per organism. All gel
pieces were cut into smaller cubes and washed twice with water followed by 50%
(v/v) acetonitrile for 10min. The acetonitrile was replaced with 50mM ammonium
bicarbonate and incubated for 10min, and repeated two more times. All the gel pieces
were then incubated in 100% acetonitrile until they turned white, after which the gel
pieces were dried in vacuo. Proteins were reduced with 10mM DTT for 1h at 57◦C.
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This was followed by brief washing steps of ammonium bicarbonate followed by 50%
acetonitrile before proteins were alkylated with 55mM iodoacetamide for 1h in the
dark.
Following alkylation the gel pieces were washed with ammonium bicarbonate for
10 min followed by 50% acetonitrile for 20min, before being dried in vacuo. The
gel pieces were digested with 100µl of a 10ng/µl trypsin solution at 37◦C overnight.
The resulting peptides were extracted twice with 70% acetonitrile in 0.1% formic
acid for 30min, and then dried and stored at −20◦C. Dried peptides were dissolved
in 5% acetonitrile in 0.1% formic acid and 10µl injections were made for nano-LC
chromatography.
All mycobacterial growth, protein preparation and tryptic peptide preparation
steps were carried out by Julian Peters in this Laboratory.
Mass spectrometry
All experiments were performed on a Thermo Scientific EASY-nLC II connected
to a LTQ Orbitrap Velos mass spectrometer (Thermo Scientific, Bremen, Germany)
equipped with a nano-electrospray source. For liquid chromatography, separation was
performed on an EASY-Column (2cm, ID 100µm, 5µm, C18) pre-column followed by
a EASY-column (10cm, ID 75µm, 3µm, C18) column with a flow rate of 300nl/min.
The gradient used was from 5− 15%B in 5min, 15− 35% B in 90min, 35− 60% B in
10min, 60− 80% B in 5min and kept at 80% B for 10min. Solvent A was 100% water
in 0.1% formic acid, and solvent B was 100% acetonitrile in 0.1% formic acid. MS/MS
data was acquired from the Orbitrap Velos in top 20 CID mode by Dr Salomie Smit
(University of Stellenbosch).
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Data analysis
Raw MS/MS data files were converted to MS2 format prior to analysis using database
search algorithms. The CRUX [31] database search engine was used as the compu-
tational program to interpret the MS/MS spectra. CRUX basically utilizes similar
algorithms as Sequest for the peptide matching scoring but has decreased peptide
candidate retrieval time and better back-end statistics to estimate the false discovery
rates. CRUX uses on-the-fly decoy databases to evaluate the statistical significance
of a Peptide Spectral Match (PSM). The decoy database is generated by shuﬄing the
target peptides ensuring that each decoy peptide has the same amino acid compo-
sition and total mass as the corresponding target peptide [31]. The False Discovery
Rate (FDR) is then estimated based upon the decoy PSMs and a q-value is reported
along with each PSM. The FDR is defined as the expected value of the number of
false positive features over the number of all expected features. And the q-value is
estimated by Equation 4.1 [32].
q(pi) = min
t>pi
F̂DR(t) (4.1)
The FDR was set to 1% in our experience. Carbamidomethylation was chosen
as a fixed modification whilst oxidation of methionine residues was set as a variable
modification. Three missed cleavages were allowed and initial peptide mass tolerance
was set at 10ppm whilst fragment mass tolerance was set to 0.5 Da.
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4.3 Results
4.3.1 Mycobacterium avium
Mycobacterium avium is included in the MAC group which is the most commonly
found group of non-tuberculosis mycobacterial in human samples [33]. M . avium
is a well annotated manually curated (as distinct from automated annotation-only)”
organism containing 5475491 nucleotides and 5120 predicted protein-coding genes
where 5040 are non-redundant set and 143 are known as pseudogenes. Pseudogenes
can be defined as genomic DNA sequences similar to normal genes but predicted
to be non-functional; they are regarded as defunct descendant of functional genes
[34]; in most cases the pseudogenes were annotated as such because of frameshifts in
the genes. The predicted proteome of M. avium can be found at different sources
such as Ensembl, Uniprot and Integr8 [28]. However, the proteomic studies of M .
avium often result in many un-interpreted spectra when matching them against the
M . avium proteome database. This suggests perhaps that some true proteins are
not present in the predicted proteome database. Hence, the use of the six frame
translation database may allows new PSMs and more inferred proteins as a result
of potential new ORFs. The genome sequence of M . avium used for the six frame
translation was obtained from the ENA (European Nucleotide Archive) database [35].
We were able to identify 1594 M. avium proteins in total from the MS/MS data
searched against the six frame translation database. Comparing this result with that
using the Ensembl proteome database of M. avium, 81 new proteins were identified
from the MS/MS data using the six frame translation. To verify the significance of
these proteins we did two analyses: (i) first looking at the position of the proteins in
the M. avium chromosome (Coordinate search) and then (ii) searching them against
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the Uniprot database (BLAST search).
Coordinate search
We made use of DAS (Distributed Annotation System) technology [36] in Ensembl for
the coordinate search of the 81 newly identified proteins in the M. avium Ensembl
chromosome and to locate the peptides that have been identified by the MS/MS
spectra to predict these proteins. This was performed by creating a new DAS track
for the MS peptides and the six frame translation which allows the visualisation of
the proteins and peptides (that uniquely matched these proteins) in the M. avium
chromosome in the Ensembl viewer according to their coordinates in the genome
sequence, an example is shown in Figure 4.1. These peptides are unique to these
protein
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A)
>CP000479.1_3_76239_76730
MAGDTTITVVGNLTADPELRFTPSGAAVANFTVASTPRIYDRQSGEWKDGEALFLRCNIW
REAAENVAESLTRGSRVIVTGRLKQRSFETREGEKRTVVEVEVDEIGPSLRYATAKVNKA
SRSGGGGGGFGGGSRQQSAPASSAPADDPWGSASASGSFGWRR
B)
Figure 4.1: A) Sequence of an identified protein reported in Ensembl as a pseudo-
gene, with peptides identified from the MS/MS analysis highlighted. B) The protein
displayed on the Ensembl chromsome of M. avium with the identified peptides (grey)
and protein predicted from the 6-frame translation (green).
From the coordinate search in the M. avium chromosome, we found that 34 of
the 81 new proteins overlap with known pseudogenes in the M. avium chromosome.
Figure 4.1 shows an example of an identified protein previously known as a pseudogene
where 3 unique peptides have been identified from MS/MS to predict this protein.
Given the number of observed peptides, there is therefore strong evidence that the
current assignment of this chromosomal segment as a pseudogene is incorrect and is
most likely due to DNA sequencing errors, although sequence differences between the
M . avium isolates used here and in the genome sequencing cannot yet be excluded.
Some of the newly identified non-pseudogenes lie on genes read in another strand as
shown for example in Figure 4.2 where our prediction is a sequence on the forward
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strand overlapping with an annotated protein on the reverse strand. This new protein
has been identified by 3 peptides from the MS/MS analysis. Other newly identified
proteins overlap with part of two genes as shown in Figure 4.3, where the newly
identified protein and the coded proteins it overlaps are read in different frames.
Interestingly, yet other proteins were found in blank regions of the chromosome not
overlapping any existing proteins in M . avium, as illustrated in Figure 4.4.
A)
>CP000479.1_1_5024065_5024457
MALTEEDTAVNFNPSHSGPSGGAFRAPTPAAGPSGDAAPTERLTSIRQPGGPRVPSGPPANQA
GRTQRTRRTVDLPAATHRALDIWQREAADRLGVARVTGQEVLTALIDQLLVDPKLTAQITRA
IKERR
B)
Figure 4.2: A) Sequence of an identified protein on the forward strand overlapping
with a protein on the reverse strand with 3 peptides identified from the MS/MS
spectra matching the former. B) The protein displayed on the Ensembl chromosome
of M. avium.
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A)
>CP000479.1_3_4375743_4376018
MRCAETTRTSVGTSNSASAAAASAITDQSLSLPMITATRGASVTLIDAAPVRVGPIRPSTARG
TASAPPARRAAAARPARPCRRRGSRRGS
B)
Figure 4.3: A) Sequence of an identified protein overlapping part of two proteins
with one unique peptide identified from the MS/MS spectra. B) Identified protein
displayed in the Ensembl chromosome of M. avium. The newly identified protein is
not read in the same frame as any of the two proteins it overlaps.
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A)
>CP000479.1_6_1853344_1853598
MEDICHECGFDQSRTPPRTVAEALPPVARAIGDGIRAISDDELRRRPTPAVWSLLEYVGHLRE
SMAFHRWLVVLTTDVRYGVVW
B)
Figure 4.4: A) Sequence of an identified protein situated in a blank region in the chro-
mosome with one unique peptide identified from the MS/MS spectra. B) Identified
protein shown on the chromosome, lying between two known proteins.
BLAST search
BLAST (Basic Local Alignment Search Tool) [37] is a set of similarity search programs
designed to run sequences against the available sequence databases. It can be used
for DNA as well as protein sequences. We used a BLAST search here to retrieve the
possible functions of the 81 newly predicted proteins from their similarity with other
known proteins. The 81 proteins were searched against the whole Uniprot database
from the FTP server using the blastp (BLAST for proteins) tool of the BLAST version
2.2.25+. Significant matches were determined based on a similarity of at least 50%
and E-value of less than 10.
The BLAST search result revealed that 34 of the 81 identified proteins have sig-
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nificant match to another species, with 24 matching characterized proteins and 10
matching putative uncharacterised proteins. Although the whole Uniprot database
was used for the BLAST search, highest similarity matches were made with proteins
from mycobacterial species which is not surprising looking at the phylogenetic re-
latedness of mycobacterial species as shown in the previous Chapter. From the 81
proteins, 39 did not have significant match (a significant match being considered as
greater than or equal to 50% similarity) with any proteins from other organisms and
the remaining 8 did not have any hit at all, so these may all be considered as potential
novel proteins.
Combined result
The summary of the combined result from BLAST coordinate searches on the chro-
mosome is illustrated in Figure 4.5.
Interestingly, 23 of the newly identified proteins that are currently annotated as
pseudogenes in the M. avium chromosome hit characterized proteins in other species
with significant scores. The list of these 23 proteins is given in Table 4.1 with their
top BLAST hit.
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Figure 4.5: Summary of the result obtained from combining BLAST and coordinate
searches. Of the 81 identified proteins, 34 overlap with known pseudogenes; 29 of these
34 match some known predicted protein in the mycobacterium databases, whilst 5
do not; these 5 are not pseudogenes because they are read in a different frame to the
overlapping pseudogene. Of the remaining 47 identified proteins that do not overlap
with pseudogenes, 42 do not show any significant matches to anything in the UniProt
database; these are therefore interesting candidates for further study.
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Table 4.1: List of proteins previously annotated as pseudogenes but which have sig-
nificant matches with characterised proteins from other species and for which we have
peptides evidence.
Protein ID Top BLAST ID Description
CP000479.1 1 1464733 1465263 Q73X40 : Arginine-tRNA ligase
CP000479.1 1 953548 954963 Q742K6 : Citrate synthase
CP000479.1 3 1023762 1024790 F7P3V 7 : Mg-chelatase subunit ChlI
CP000479.1 3 76239 76730 Q744V 5 : Single-stranded DNA-binding protein
CP000479.1 3 1463610 1464935 F7P506 : Arginine-tRNA ligase
CP000479.1 3 2424678 2425244 F7P1Z1 : Proteasome accessory factor PafA2
CP000479.1 4 3868953 3870401 Q73V Q8 : AmiC
CP000479.1 6 3968887 3970191 Q73V I4 : Glutamate-tRNA ligase
CP000479.1 4 4330578 4333205 F7P8Q8 : Protein translocase subunit SecA 1
CP000479.1 6 4350169 4350969 F7P8P2 : Phosphomannomutase
CP000479.1 2 1024739 1025155 Q9KII9 : Rv0958-like protein
CP000479.1 5 1344512 1345201 A4KGH1 : 2-oxoglutarate dehydrogenase sucA
CP000479.1 5 222098 224686 P71486 : Probable arabinosyltransferase B
CP000479.1 4 4335282 4336247 F7P8Q5 : Sporulation/spore germination protein
CP000479.1 5 2184665 2186083 Q73Y E8 : AdhE2
CP000479.1 2 1724666 1725664 F7PCE7 : Small-conductance mechanosensitive channel
CP000479.1 4 964089 964796 Q742J6 : AccD3
CP000479.1 6 3980053 3980766 F7P9X3 : Acetolactate synthase, large subunit
CP000479.1 5 3978899 3980185 Q73V H5 : Acetolactate synthase
CP000479.1 2 2423735 2425210 F7P1Z1 : Proteasome accessory factor PafA2
CP000479.1 6 1344619 1348272 Q73WX4 : 2-oxoglutarate decarboxylase
CP000479.1 3 2802039 2802992 F7PEJ9 : Transcriptional regulator
CP000479.1 4 844704 845249 Q1B5H3 : Transcriptional regulator, TetR family
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Figure 4.1 shows an example of one such newly identified protein having a signif-
icant match with proteins in other species that are involved in the ”single stranded
DNA binding” pathway, yet it is currently annotated as a pseudogene in M. avium.
From the 81 newly identified proteins, 5 overlap known pseudogenes in the M. avium
chromosome but are not read in the same reading frame and they do not have any
significant match in any other organisms. An example of such a protein is illustrated
in Figure 4.6 which is read in the reverse strand while the pseudogene is in the forward
strand.
A)
>CP000479.1_4_5339505_5340095
MASLWARRSASSSVHRAGTVIGRAASASHSADITEPMSPASGAAICWLLSNSDGSMSTWTN
LTPADHCGDSPCPRSQFSRAPTNSTASARPTASERAAATDCGCASGSSPLAIDIGRNGIPVHST
NRRISLSAWAYAAPLPSTINGRRALVSTSSARSSASGAGSWRGAGSTTRHSVPAAAEASMA
WPRTSPGMSR
B)
Figure 4.6: A) Sequence of an identified protein on the reverse strand overlapping
with a pseudogene on the forward strand. It does not have any significant match to
proteins from other species. B) Location of the protein on the M. avium chromosome.
Figure 4.5 shows that almost all of our newly identified proteins that match
characterized proteins in a BLAST search (23 out of 24) are currently annotated
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as pseudogenes in M. avium. Only one non-pseudogene overlapping a part of an
existing gene in the chromosome matched a characterized protein, which is Q83YL6
in Mycobacterium fortuitum, functionally annotated as a ’Putative transposase’.
The coordinate of this identified proteins on the M. avium chromosome is shown in
Figure 4.7.
A)
>CP000479.1_4_1443957_1444451
MGVVRSHRPQSSPCRRRPGRRCPRGRSWSHPAPQNRQHPSPAGLPSTPTHLAPTNALALGR
SLDHVVVQHHRPQSTNNRDYLTTSPNRPNRSTQEKLDRPATTSCEHAAPPTEITVEPHQPG
QSTDRGLAAAVCRAMRLLRSVQPPCNSHPIGTRQNLTDGNTV
B)
Figure 4.7: A) Sequence of the only identified protein overlapping with a non-
pseudogene which hits a characterized protein in other species. B) Location of the
protein on the M . avium chromosome; it is read in a different frame to the overlap-
ping coded protein.
From the identified proteins overlapping non-pseudogenes, 4 matched hypothetical
(i.e uncharacterised) proteins in other organisms and one of these is shown in Figure
4.4. Notably, of the 47 proteins overlapping non pseudogenes, 35 have no significant
match (significance being greater than or equal to 50% similarity), (Figure 4.3 is one
such example) and 7 proteins of this set did not have any hit in the BLAST search
at all. An example of these 7 proteins is shown in Figure 4.8 which represents a very
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short protein, with length 26 containing only 2 tryptic peptides of length 3 and 23
respectively but where the longer peptide has been identified by the MS/MS analysis.
Only 5 non-pseudogenes overlapping proteins are present in other species of which 4
of them match hypothetical uncharacterised proteins.
A)
>CP000479.1_5_1333265_1333345
MAKRPPNCLVQSWAIAANVAPSVAVV
B)
Figure 4.8: ) Sequence of an identified short protein with no hit from other species.
B) Location of this protein on the M. avium chromosome; it is read in different frame
to the overlapping coded protein.
Overall, we found that most of the 81 extra proteins identified experimentally from
the M . avium sample have evidence and significance to be real based on similarity
to proteins annotated in other organisms. Although M. avium is thought to be
well annotated, the result obtained here reveals that it is in fact incomplete and
some ORFs previously known as pseudogenes are real. Possible functions of these
proteins were assigned from their significant match with other known characterized
proteins. Out of the 81 newly identified proteins here, 47 likely represent potential
novel proteins because they have no significant match to any known protein in any
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organism; these therefore warrant further study.
4.3.2 Mycobacterium kansasii
After M. avium complex organisms, M. kansasii infection is the second most com-
mon non-tuberculous opportunistic mycobacterial infection associated with AIDS.
Unlike M. avium, M. kansasii has been poorly annotated as only 83 proteins are
available in Uniprot corresponding to this organism. This species was discovered in
1953 and was sequenced in 2008 by Veyrier F. et.al [38] but the 5913 annotated pro-
teins in Refseq from the Whole Genome Sequencing(WGS) [39] were obtained from
automated annotation and interestingly have not been included yet in the Uniprot
database. Other sources like Ensembl or ENA contain only the genome sequence of
this species.
Using the six frame translation database of M . kansasii to search our MS/MS
data, we identified only 160 proteins. Interestingly, we found a much higher number
(660) of proteins by searching the MS/MS data against the M . avium six frame
translation file. This observation caused us to question both the reliability of the
genome sequence for M. kansasii, as well as the identity of the M. kansasii clinical
isolate that gave rise to the experimental MS/MS data.
Comparison of the 16S rRNA sequence for theM. kansasii whole genome sequence
to other M. kansasii 16S rRNA sequences obtained from the myRDP database [22]
showed very high homology. Furthermore, searching the 83 M. kansasii proteins
present in Uniprot against the automated translation of the WGS data showed high
homology matches in all cases. Together, these lines of evidence appear to verify the
WGS M. kansasii data.
At the present time, 16S rRNA sequencing of our M. kansasii isolate suggests
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that in fact our isolate may not be M. kansasii. However, further work is needed to
unravel this situation because the closest 16S rRNA match is to Peanibacillus species
and not to any mycobacteria, yet a search of the MS/MS data against the whole
Uniprot bacteria database returned more hits to M . avium than any other organism
by some considerable margin.
It is an interesting twist that the proteogenomic analysis of the MS/MS data has
demonstrated that our M. kansasii strain is in fact not M. kansasii; the discordant
results of the 16s rRNA sequencing and the MS/MS data suggest that further ex-
perimental identification of this clinical isolate is warranted. Further discussion of
the MS/MS data from our M. kansasii isolate is therefore beyond the scope of this
thesis.
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5. Conclusion
Summary
Two approaches have been described in this thesis to enable database searches of
proteomic data for incomplete or non-annotated organisms. The first one consists of
the use of the closest annotated species database and the second one is a proteoge-
nomic analysis using an automated six frame translation database generated from the
genomic data. The survey of this work and a future proposed workflow can be sum-
marized in the Figure 5.1. For any species in mycobacteria, if it is annotated with a
complete database, a normal database search method can be done using the existing
database. If the species is not annotated, the feasibility of a cross-species analysis
is tested by first computing the distance of the species with its closest sequenced
organism and then by estimating the percentage of identical peptides between them.
The cross-species analysis is feasible if the estimated number of identical peptides is
high enough with an acceptable false positive rate. In the case that the cross-species
analysis becomes non-significant for non-annotated species or if the species has been
annotated but incompletely, a proteogenomic analysis can then be applied.
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Figure 5.1: Workflow of this study, which can potentially be used for future analyses.
The study of the comparison of identical peptides between mycobacterial species
revealed the strong conservation of 2600 peptides across all mycobacterial species
representing around 700 proteins in each organism including about the half of the
M. leprae proteome. We have shown that the cross species analysis is applicable
for non-annotated organisms if its phylogenetic distance with a sequenced and anno-
tated organism is small enough, such as those within MTBC or MAC. This approach
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stops being viable when the phylogenetic distance to the nearest annotated organism
increases, particularly beyond 0.3; in such circumstances, the use of proteogenomic
analysis becomes the preferable approach.
The proteogenomic analysis ofM. avium revealed the incompleteness of its database
even though M. avium is known as a well annotated species among mycobacteria. We
have shown that 81 proteins not included in the existing M. avium database have ex-
perimental evidence from the MS/MS spectra; 34 of these proteins were subsequently
found to have significant match with proteins in other species that are involved in
important pathways and 47 did not and so are likely to be novel proteins. There were
34 proteins previously annotated as pseudogenes in the M. avium chromosome that
are shown here to have experimental evidence.
Future work
Our study here highlighted the importance of a cross-species analysis for mycobac-
terial species with phylogenetic distance less than 0.3 to each other. If we have
non-annotated mycobacterial species having phylogenetic distance less than 0.3 with
a well annotated species, then its closest species database can be used for an MS
analysis. Our study was limited to mycobacterial species, all analysis were made us-
ing these species, but it can obviously be extended to and tested with other species
outside the mycobacteria. Our future plan therefore consists of extending the cross-
species analysis to other organisms to see if the distance limit remains the same and
if we can generalize this pattern.
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